{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:22:28Z","timestamp":1790893348812,"version":"4.1.0"},"reference-count":57,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T00:00:00Z","timestamp":1229385600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Nutr"],"abstract":"<jats:p>Some countries have introduced mandatory folic acid fortification, whereas others support periconceptional supplementation of women in childbearing age. Several European countries are considering whether to adopt a fortification policy. Projections of the possible beneficial effects of increased folic acid intake assume that the measure will result in a considerable reduction in neural-tube defects (NTD) in the target population. Therefore, the objective of the present study is to evaluate the beneficial effects of different levels of folic acid administration on the prevalence of NTD. Countries with mandatory fortification achieved a significant increase in folate intake and a significant decline in the prevalence of NTD. This was also true for supplementation trials. However, the prevalence of NTD at birth declined to approximately five cases at birth per 10\u00a0000 births and seven to eight cases at birth or abortion per 10\u00a0000 births. This decline was independent of the amount of folic acid administered and apparently reveals a \u2018floor effect\u2019 for folic acid-preventable NTD. This clearly shows that not all cases of NTD are preventable by increasing the folate intake. The relative decline depends on the initial NTD rate. Countries with NTD prevalence close to the observed floor may have much smaller reductions in NTD rates with folic acid fortification. Additionally, potential adverse effects of fortification on other vulnerable population groups have to be seriously considered. Policy decisions concerning national mandatory fortification programmes must take into account realistically projected benefits as well as the evidence of risks to all vulnerable groups.<\/jats:p>","DOI":"10.1017\/s0007114508149200","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T09:49:36Z","timestamp":1229420976000},"page":"173-180","source":"Crossref","is-referenced-by-count":96,"title":["Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid"],"prefix":"10.1017","volume":"102","author":[{"given":"Helmut B.","family":"Heseker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Selhub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin H.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2008,12,16]]},"reference":[{"key":"S0007114508149200_ref29","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20086"},{"key":"S0007114508149200_ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067103"},{"key":"S0007114508149200_ref25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0592"},{"key":"S0007114508149200_ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-001-0265-4"},{"key":"S0007114508149200_ref18","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1827"},{"key":"S0007114508149200_ref11","unstructured":"11 Food Standards Agency (2008) Folic Acid Fortification. http:\/\/www.food.gov.uk\/healthiereating\/folicfortification."},{"key":"S0007114508149200_ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602315"},{"key":"S0007114508149200_ref55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709487104"},{"key":"S0007114508149200_ref19","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20394"},{"key":"S0007114508149200_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tifs.2005.03.012"},{"key":"S0007114508149200_ref27","first-page":"237","article-title":"Incidence of neural tube defects in Ontario, 1986\u20131999","volume":"167","author":"Gucciardi","year":"2002","journal-title":"CMAJ"},{"key":"S0007114508149200_ref13","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20307"},{"key":"S0007114508149200_ref31","first-page":"10","article-title":"Prevalence of neural tube defects and folic acid knowledge and consumption \u2013 Puerto Rico, 1996\u20132006","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"S0007114508149200_ref24","first-page":"362","article-title":"Spina bifida and anencephaly before and after folic acid mandate \u2013 United States, 1995\u20131996 and 1999\u20132000","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"S0007114508149200_ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7360.391"},{"key":"S0007114508149200_ref39","first-page":"1377","article-title":"Folate status in women of childbearing age, by race\/ethnicity \u2013 United States, 1999\u20132000, 2001\u20132002, and 2003\u20132004","volume":"55","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"S0007114508149200_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3016.2005.00675.x"},{"key":"S0007114508149200_ref51","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/87.3.517"},{"key":"S0007114508149200_ref49","first-page":"69","article-title":"Mandatory fortification with folic acid \u2013 what would Hippocrates say?","volume":"36","author":"Lawrence","year":"2007","journal-title":"Aust Fam Physician"},{"key":"S0007114508149200_ref9","first-page":"468","article-title":"Strategien zur Verbesserung der Folatver-sorgung in Deutschland \u2013 Nutzen und Risiken","volume":"53","author":"Krawinkel","year":"2006","journal-title":"Ernaehrungs-Umschau"},{"key":"S0007114508149200_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90133-A"},{"key":"S0007114508149200_ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911113412001"},{"key":"S0007114508149200_ref56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.22.2720"},{"key":"S0007114508149200_ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30651"},{"key":"S0007114508149200_ref47","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20210"},{"key":"S0007114508149200_ref10","volume-title":"Folate and Disease Prevention","year":"2006"},{"key":"S0007114508149200_ref28","doi-asserted-by":"publisher","DOI":"10.1097\/01.EDE.0000040253.12446.B2"},{"key":"S0007114508149200_ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30057"},{"key":"S0007114508149200_ref17","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20075"},{"key":"S0007114508149200_ref12","unstructured":"12 White Junod S (2001) Folic Acid Fortification: Fact and Folly. Food and Law Institute: update issues 4, 5, 6. http:\/\/www.fda.gov\/oc\/history\/makinghistory\/folicacid.html."},{"key":"S0007114508149200_ref45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38336.664352.82"},{"key":"S0007114508149200_ref50","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.1.3"},{"key":"S0007114508149200_ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031145"},{"key":"S0007114508149200_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1028-4559(08)60071-6"},{"key":"S0007114508149200_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2005.03.015"},{"key":"S0007114508149200_ref30","doi-asserted-by":"publisher","DOI":"10.1080\/08035250500340396"},{"key":"S0007114508149200_ref21","first-page":"206","article-title":"Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India","volume":"112","year":"2000","journal-title":"Indian J Med Res"},{"key":"S0007114508149200_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2005.03.009"},{"key":"S0007114508149200_ref33","first-page":"2462","article-title":"Congenital malformations","volume":"103","author":"Queisser-Luft","year":"2006","journal-title":"Dtsch Aertzebl"},{"key":"S0007114508149200_ref38","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2005.10719474"},{"key":"S0007114508149200_ref34","first-page":"53254","article-title":"Food labeling: health claims and labeling statements: folate and neural tube defects","volume":"58","year":"1993","journal-title":"Fed Regist"},{"key":"S0007114508149200_ref35","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.5.1409"},{"key":"S0007114508149200_ref36","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/132.9.2792"},{"key":"S0007114508149200_ref37","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/82.2.442"},{"key":"S0007114508149200_ref40","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/86.3.718"},{"key":"S0007114508149200_ref41","doi-asserted-by":"publisher","DOI":"10.1053\/jada.2003.50030"},{"key":"S0007114508149200_ref42","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000260493.24573.15"},{"key":"S0007114508149200_ref43","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e31815b8ec5"},{"key":"S0007114508149200_ref44","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/86.5.1773"},{"key":"S0007114508149200_ref1","doi-asserted-by":"publisher","DOI":"10.1079\/PNS2006495"},{"key":"S0007114508149200_ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3016.2005.00633.x"},{"key":"S0007114508149200_ref48","first-page":"1","article-title":"Folate intake, markers of folate status and oral clefts: is the evidence converging?","volume":"26","author":"Johnson","year":"2008","journal-title":"Int J Epidemiol"},{"key":"S0007114508149200_ref52","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.21.2408"},{"key":"S0007114508149200_ref53","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0329"},{"key":"S0007114508149200_ref54","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.1.193"},{"key":"S0007114508149200_ref57","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/88.2.348"},{"key":"S0007114508149200_ref8","volume-title":"Report of the National Committee on Folic Acid Food Fortification","year":"2006"}],"container-title":["British Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007114508149200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T18:57:54Z","timestamp":1554404274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007114508149200\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,16]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,7,28]]}},"alternative-id":["S0007114508149200"],"URL":"https:\/\/doi.org\/10.1017\/s0007114508149200","relation":{},"ISSN":["0007-1145","1475-2662"],"issn-type":[{"value":"0007-1145","type":"print"},{"value":"1475-2662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,16]]}}}